Literature DB >> 23275592

PET findings of intramedullary tumors of the spinal cord using [18F] FDG and [11C] methionine.

N Tomura1, Y Ito, H Matsuoka, T Saginoya, S-I Numazawa, Y Mizuno, K Watanabe.   

Abstract

BACKGROUND AND
PURPOSE: Only a few reports on intramedullary tumors of the spinal cord using PET have been published. We report findings of PET by using [(18)F] fluorodeoxyglucose and [(11)C] methionine and discuss the usefulness of the findings in patients with intramedullary tumors of the spinal cord.
MATERIALS AND METHODS: PET/CT was performed in 9 patients with intramedullary tumors of the spinal cord: Six had ependymomas, 1 had an anaplastic astrocytoma, 1 had a hemangioblastoma, and 1 had a cavernous angioma. The maximum standardized uptake value of the tumor was measured and compared with pathologic findings.
RESULTS: The SUVmax of FDG and MET in a case of anaplastic astrocytoma was high. The SUVmax of FDG and MET was relatively high in 4 of 6 cases of ependymoma (excluding myxopapillary ependymomas). A case of hemangioblastoma showed decreased uptake of both FDG and MET (SUVmax = 2.0 and 1.4, respectively). Three cases with hemorrhage (1 case of ependymoma, 1 case of cellular ependymoma, and 1 case of cavernous angioma) showed a relatively increased uptake of FDG.
CONCLUSIONS: Both FDG and MET accumulated to a large degree in an anaplastic astrocytoma and accumulated in ependymomas (excluding a myxopapillary ependymoma). FDG can accumulate in tumors with hemorrhage. More investigation of a larger number of patients is required to evaluate the diagnostic value of PET with FDG and MET for imaging intramedullary tumors of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275592      PMCID: PMC7964572          DOI: 10.3174/ajnr.A3374

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  Understanding the standardized uptake value, its methods, and implications for usage.

Authors:  Joseph A Thie
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

2.  The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature.

Authors:  Daniel R Fassett; James Pingree; John R W Kestle
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

Review 3.  Positron emission tomography imaging of brain tumors.

Authors:  Terence Z Wong; Gert J van der Westhuizen; R Edward Coleman
Journal:  Neuroimaging Clin N Am       Date:  2002-11       Impact factor: 2.264

4.  Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine.

Authors:  T Sasajima; K Mineura; Y Itoh; M Kowada; J Hatazawa; T Ogawa; K Uemura
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

5.  Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.

Authors:  Ji Hoon Phi; Jin Chul Paeng; Hyo Sang Lee; Kyu-Chang Wang; Byung-Kyu Cho; Ji-Yeoun Lee; Sung-Hye Park; Joongyub Lee; Dong Soo Lee; Seung-Ki Kim
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

6.  Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.

Authors:  Lise Borgwardt; Liselotte Højgaard; Henrik Carstensen; Henning Laursen; Markus Nowak; Carsten Thomsen; Kjeld Schmiegelow
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

7.  Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.

Authors:  Yong Hwy Kim; So Won Oh; You Jung Lim; Chul-Kee Park; Se-Hoon Lee; Keon Wook Kang; Hee-Won Jung; Kee Hyun Chang
Journal:  Clin Neurol Neurosurg       Date:  2010-07-08       Impact factor: 1.876

8.  Positron emission tomography in imaging spinal cord tumors.

Authors:  J M Wilmshurst; S F Barrington; D Pritchard; T Cox; P Bullock; M Maisey; R O Robinson
Journal:  J Child Neurol       Date:  2000-07       Impact factor: 1.987

9.  Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data.

Authors:  P Smeets; H Ham; W Ceelen; T Boterberg; K Verstraete; I Goethals
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-02-18       Impact factor: 2.346

10.  The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer.

Authors:  Pablo Palma; Raquel Conde-Muíño; Antonio Rodríguez-Fernández; Inmaculada Segura-Jiménez; Rocío Sánchez-Sánchez; Javier Martín-Cano; Manuel Gómez-Río; José A Ferrón; José M Llamas-Elvira
Journal:  Radiat Oncol       Date:  2010-12-15       Impact factor: 3.481

View more
  9 in total

Review 1.  Radiopharmaceuticals as probes to characterize tumour tissue.

Authors:  Israt S Alam; Mubarik A Arshad; Quang-Dé Nguyen; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

2.  Genetics of Von Hippel-Lindau Disease.

Authors:  D C Dwyer; R K Tu
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-17       Impact factor: 3.825

3.  Intramedullary spinal cord metastases: visibility on PET and correlation with MRI features.

Authors:  P M Mostardi; F E Diehn; J B Rykken; L J Eckel; K M Schwartz; T J Kaufmann; C P Wood; J T Wald; C H Hunt
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

4.  18F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumor.

Authors:  Sied Kebir; Okka Kimmich; Pitt Niehusmann; Florian C Gaertner; Markus Essler; Jennifer Landsberg; Thomas Klockgether; Matthias Simon; Ulrich Herrlinger; Martin Glas
Journal:  Oncol Lett       Date:  2016-10-10       Impact factor: 2.967

5.  The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord.

Authors:  Caroline Tscherpel; Veronika Dunkl; Garry Ceccon; Gabriele Stoffels; Natalie Judov; Marion Rapp; Philipp T Meyer; Elena Rota Kops; Johannes Ermert; Gereon R Fink; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

Review 6.  [18F]FDG-PET Evaluation of Spinal Pathology in Patients in Oncology: Pearls and Pitfalls for the Neuroradiologist.

Authors:  P Y Patel; I Dalal; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-28       Impact factor: 3.825

7.  "Drop" Metastases from an Operated Case of Intracranial Anaplastic Ependymoma Identified on Fluoro-2-deoxyglucose Positron Emission Tomography/Computed Tomography.

Authors:  Piyush Chandra; Nilendu Purandare; Sneha Shah; Archi Agrawal; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2017 Jan-Mar

8.  The impact of MR-based attenuation correction in spinal cord FDG-PET/MR imaging for neurological studies.

Authors:  Valentina Brancato; Pasquale Borrelli; Vincenzo Alfano; Marco Picardi; Mario Mascalchi; Emanuele Nicolai; Marco Salvatore; Marco Aiello
Journal:  Med Phys       Date:  2021-09-13       Impact factor: 4.506

9.  Imaging Spectrum and Pitfalls of (11)C-Methionine Positron Emission Tomography in a Series of Patients with Intracranial Lesions.

Authors:  Kimiteru Ito; Hiroshi Matsuda; Kazoo Kubota
Journal:  Korean J Radiol       Date:  2016-04-14       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.